Derivation of a nuclear heterogeneity image index to grade DCIS

Uhler, 2018, Nuclear mechanopathology and cancer diagnosis, Trends Cancer, 4, 320, 10.1016/j.trecan.2018.02.009 Lester, 2009, Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast, Arch Pathol Lab Med, 133, 15, 10.5858/133.1.15 Sanders, 2005, The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up, Cancer, 103, 2481, 10.1002/cncr.21069 Collins, 2005, Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study, Cancer, 103, 1778, 10.1002/cncr.20979 Badve, 1998, Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up, Hum Pathol, 29, 915, 10.1016/S0046-8177(98)90196-4 Onega, 2017, The diagnostic challenge of low-grade ductal carcinoma in situ, Eur J Cancer, 80, 39, 10.1016/j.ejca.2017.04.013 Mokbel, 2006, Heterogeneity of ductal carcinoma in situ and its effects on management, Lancet Oncol, 7, 756, 10.1016/S1470-2045(06)70861-0 Allegra, 2010, National institutes of health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009, JNCI J National Cancer Inst, 102, 161, 10.1093/jnci/djp485 Badve, 2015, Tumor Heterogeneity in Breast Cancer, Adv Anat Pathol, 22, 294, 10.1097/PAP.0000000000000074 Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee. Cancer, 1997;80(9):1798–802. Bankhead, 2017, QuPath: Open source software for digital pathology image analysis, Sci Rep, 7, 16878, 10.1038/s41598-017-17204-5 Dong, 2014, Computational pathology to discriminate benign from malignant intraductal proliferations of the breast, PLoS ONE, 9, 10.1371/journal.pone.0114885 Klimov, 2019, A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk, Breast Cancer Res, 21, 83, 10.1186/s13058-019-1165-5 Axelrod, 2008, Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast, Cancer Inform, 6, 99, 10.4137/CIN.S401 Burstein, 2004, Ductal carcinoma in situ of the breast, N Engl J Med, 350, 1430, 10.1056/NEJMra031301 Lagios, 1995, Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation, Cancer Lett, 90, 97, 10.1016/0304-3835(94)03683-A Kerlikowske, 2003, Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy, J Natl Cancer Inst, 95, 1692, 10.1093/jnci/djg097 Lester, 2009, College of American Pathologists protocol for the reporting of ductal carcinoma in situ, Arch Pathol Lab Med, 133, 13, 10.5858/133.1.13 Hipp, 2011, Computer aided diagnostic tools aim to empower rather than replace pathologists: Lessons learned from computational chess, J Pathol Inform, 2, 25, 10.4103/2153-3539.82050 Hammond, 2010, American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer, J Oncol Pract, 6, 195, 10.1200/JOP.777003 Sinn HP, Kreipe H, A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. Breast Care (Basel), 2013;8(2):149–54. Chapman, 2007, Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment, BMC Cancer, 7, 174, 10.1186/1471-2407-7-174 Tan, 2001, Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast, Mod Pathol, 14, 937, 10.1038/modpathol.3880415 Miller, 2010, Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast, Cancer Inform, 9, 209, 10.4137/CIN.S5505 Veta, 2012, Prognostic value of automatically extracted nuclear morphometric features in whole slide images of male breast cancer, Mod Pathol, 25, 1559, 10.1038/modpathol.2012.126 Axelrod, 2009, Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors, Biomed Inform Insights, 2, 11, 10.4137/BII.S2222 Allred, 2008, Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution, Clin Cancer Res, 14, 370, 10.1158/1078-0432.CCR-07-1127 Groen, 2017, Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS), Breast, 31, 274, 10.1016/j.breast.2016.09.001 Lennington, 1994, Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions, Cancer, 73, 118, 10.1002/1097-0142(19940101)73:1<118::AID-CNCR2820730121>3.0.CO;2-R Gerdes, 2018, Single-cell heterogeneity in ductal carcinoma in situ of breast, Mod Pathol, 31, 406, 10.1038/modpathol.2017.143 Simpson, 2005, Molecular evolution of breast cancer, J Pathol, 205, 248, 10.1002/path.1691 Sgroi, 2010, Preinvasive breast cancer, Annu Rev Pathol, 5, 193, 10.1146/annurev.pathol.4.110807.092306